Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis with a Maximum Exposure of 8.3 Years

被引：0

作者：

Withrop, Kevin ^{[1
,2
]}

Aletaha, Daniel ^{[3
]}

Caporali, Roberto F. ^{[4
,5
]}

Tanaka, Yoshiya ^{[6
]}

Takeuchi, Tsutomu ^{[7
,8
]}

Van Hoek, Paul ^{[9
]}

Stiers, Pieter-Jan ^{[10
]}

Rajendran, Vijay ^{[11
]}

Van Beneden, Katrien ^{[9
]}

Gottenberg, Jacques-Eric ^{[12
]}

Burmester, Gerd ^{[13
]}

机构：

[1] Oregon Hlth & Sci Univ, Sch Med, Portland, OR USA

[2] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR USA

[3] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria

[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[5] ASST Gaetano Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy

[6] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[7] Keio Univ, Sch Med, Tokyo, Japan

[8] Saitama Med Univ, Tokyo, Japan

[9] Galapagos NV, Med Safety, Mechelen, Belgium

[10] Galapagos NV, Biostat, Mechelen, Belgium

[11] Galapagos NV, Clin Res, Mechelen, Belgium

[12] Strasbourg Univ Hosp, Dept Rheumatol, Strasbourg, France

[13] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1325

引用

页码：2596 / 2598

页数：3

共 2 条

[1]

Winthrop K, 2022, ARTHRITIS RHEUMATOL, V74, P518

[2] Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years [J].

Winthrop, Kevin L. ;

Tanaka, Yoshiya ;

Takeuchi, Tsutomu ;

Kivitz, Alan ;

Matzkies, Franziska ;

Genovese, Mark C. ;

Jiang, Deyuan ;

Chen, Kun ;

Bartok, Beatrix ;

Jahreis, Angelika ;

Besuyen, Robin ;

Burmester, Gerd R. ;

Gottenberg, Jacques-Eric .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (02) :184-192

← 1 →